CardioSolv Ablation Technologies Overview

  • Founded
  • 2009

Founded
  • Status
  • Private

  • Employees
  • 5

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $669K

  • Investors
  • 5

CardioSolv Ablation Technologies General Information

Description

Developer of cardiac modeling and simulation technologies designed to treat patients suffering from arrhythmia. The company's technologies improve outcomes for patients who undergo ventricular tachycardia ablation procedures and reduce the procedure time and cost, enabling healthcare practitioners to improve the lives of the patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Primary Office
  • 2443 Maryland Avenue
  • Baltimore, MD 21218
  • United States
+1 (443) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioSolv Ablation Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-2019 $669K 0000 Completed Generating Revenue
4. Later Stage VC 24-Feb-2017 0000 0000 Completed Generating Revenue
3. Grant 01-Jul-2015 00.000 Completed Generating Revenue
2. Accelerator/Incubator 27-Aug-2014 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view CardioSolv Ablation Technologies’s complete valuation and funding history, request access »

CardioSolv Ablation Technologies Patents

CardioSolv Ablation Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200273170-A1 Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit Pending 03-Dec-2015 000000000
US-20170161896-A1 Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits Granted 03-Dec-2015 0000000000
US-10679348-B2 Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit Active 03-Dec-2015 0000000000
US-10402966-B2 Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits Active 03-Dec-2015 0000000000
US-20190378272-A1 Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit Granted 03-Dec-2015 G06T7/0012
To view CardioSolv Ablation Technologies’s complete patent history, request access »

CardioSolv Ablation Technologies Executive Team (7)

Name Title Board Seat Contact Info
Edward Vigmond Ph.D President & Advisor of Scientific Board
Scott Kokones Chief Operating Officer & Board Member
Gernot Plank Ph.D Advisor of the Scientific Boad & Chief Technology Officer
Natalia Trayanova Ph.D Co-Founder, Chief Scientific Officer & Board Member
Brock Tice Ph.D Co-Founder, Head of Technology & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

CardioSolv Ablation Technologies Board Members (6)

Name Representing Role Since
Brock Tice Ph.D CardioSolv Ablation Technologies Co-Founder, Head of Technology & Board Member 000 0000
Natalia Trayanova Ph.D CardioSolv Ablation Technologies Co-Founder, Chief Scientific Officer & Board Member 000 0000
Scott Kokones CardioSolv Ablation Technologies Chief Operating Officer & Board Member 000 0000
Steven Girouard Ph.D Self Board Member 000 0000
Vincent Owens Self Co-Founder, Chief Executive Officer, President & Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

CardioSolv Ablation Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CardioSolv Ablation Technologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
Guide Medical Ventures Venture Capital Minority 000 0000 000000 0
To view CardioSolv Ablation Technologies’s complete investors history, request access »